Clinical Topics & News
Guidelines for Thyroid Nodule Evaluation
Fed Pract. 2011 October;28(10):11
Author and Disclosure Information
James T. May, MD; Jarrod A. Keeler, MD; and Tapan A. Padhya, MD
With high-profile cases, such as the death of Chief Justice William Rehnquist in 2005 and recent reports demonstrating increases in thyroid cancer, thyroid nodules are gaining significance in the minds of many physicians.(1,2) Palpable thyroid nodules are estimated to occur in 5% of women and 1% of men in parts of the world with adequate iodine intake, although the overall incidence may be as high as 7%.(3-5) Further, high-resolution ultrasound and autopsy studies demonstrate nodules in as many as 67% of individuals.(6,7)
Recommended Reading
Clinical Topics
-
When cisplatin won’t do, try carboplatin in head and neck cancer -
Is early-onset cancer an emerging global epidemic? Publish date: October 5, 2022 -
Despite benefits, extended-interval pembro uptake remains low Publish date: September 28, 2022 -
Time to cancer diagnoses in U.S. averages 5 months Publish date: September 15, 2022 -
Trends in Palliative Care Utilization and Facility Type for Stage IV Esophageal Cancer: A National Cancer Database Analysis
Digital Edition
-
AVAHO 2021 Meeting Posters and Abstracts Publish date: September 22, 2021 -
Advances in Hematology and Oncology Publish date: September 3, 2021 -
Advances in Hematology and Oncology Publish date: May 20, 2021 -
August 2020 Advances in Precision Oncology -
Abstracts Presented at the 2020 AVAHO Annual Meeting (Digital Edition)
Multimedia
-
Palliative Care for Patients With Head and Neck Cancer Publish date: September 14, 2014
Conference Coverage
-
Multiprong strategy makes clinical trials less White Publish date: June 23, 2023 -
CBSM phone app eases anxiety, depression in cancer patients Publish date: June 23, 2023 -
Huge underuse of germline testing for cancer patients Publish date: June 22, 2023 -
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology Publish date: June 15, 2023 -
Metronomic chemotherapy performs well in second-line head and neck cancer Publish date: June 6, 2023 -
Radiofrequency ablation successful in small thyroid cancers Publish date: May 8, 2023 -
A farewell to arms? Drug approvals based on single-arm trials can be flawed Publish date: September 19, 2022 -
Time to cancer diagnoses in U.S. averages 5 months Publish date: September 15, 2022 -
Pembro/chemo combo fails to improve event-free survival in head and neck cancer Publish date: September 14, 2022 -
First drug for desmoid tumors: ‘Impressive’ data for nirogacestat Publish date: September 13, 2022
ATA Guidelines: Lymph node dissection & DTC
Question 1 of 5